Spanish Study for Molecular Characterization of Thyroid Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 14, 2021

Primary Completion Date

January 25, 2023

Study Completion Date

March 31, 2025

Conditions
Differentiated Thyroid CarcinomaMedullary Thyroid Carcinoma
Interventions
OTHER

Immunohistochemistry (IHC)

VENTANA pan-TRK technique (EPR17341) Assay, with Optiview DAB-detection kit and Optiview amplification kit. Using FFPE slices

OTHER

Fluorescence In-Situ Hybridization (FISH)

FISH using FFPE slices for genes: Neurotrophic tyrosin kinase 1 (NTRK1), Neurotrophic tyrosin kinase 3 (NTRK3) and rearranged during transfection (RET)

OTHER

Oncomine Focus Assay Platform with 52 genes

Oncomine Focus Assay Platform with 52 genes (35 Hotspot genes, 19 Copy number variants and 23 Gene fusions). Using FFPE slices

Trial Locations (12)

17007

Institut Català d'Oncologia Girona - ICO Girona, Girona

28034

Hospital Universitario Ramón y Cajal, Madrid

28046

Hospital Universitario La Paz, Madrid

39008

Hospital universitario Marqués de Valdecilla, Santander

46014

Hospital General Universitario de Valencia, Valencia

46026

Hospital Universitario y Politécnico La Fe, Valencia

50009

Hospital Universitario Miguel Servet, Zaragoza

08035

Hospital Universitario Vall d'Hebron, Barcelona

08036

Hospital Clínic de Barcelona, Barcelona

08908

Hospital Universitario Durán i Reinals, L'Hospitalet de Llobregat

08243

Fundació Althaia, Manresa

08208

Consorci Corporació Sanitària Parc Taulí de Sabadell, Sabadell

All Listed Sponsors
lead

Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

OTHER